Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Current Report · Items 5.07 · 8-K

Oscar Health, Inc.

OSCRNYSEEQUITYCurrent

Submission of Matters to a Vote of Security Holders

Item 5.07. Submission of Matters to a Vote of Security Holders. On June 4, 2026, Oscar Health, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”).…

Filed Jun 9, 2026Accepted Jun 9, 2026, 4:11 PM EDTCIK 1568651Accession 0001568651-26-000059
Share

Company context

Oscar Health, Inc. (“Oscar”) is a leading healthcare technology company built around a full stack technology platform and a relentless focus on serving our members. Oscar has been challenging the status quo in the healthcare system since its founding in 2012, and is dedicated to making a healthier life accessible and affordable for all. Oscar offers Individual & Family plans and health technology solutions that power the healthcare industry through +Oscar. Oscar’s technology drives superior experiences, deep engagement, and high-value clinical care, earning us the trust of approximately 2.0 million members, as of June 30, 2025.

Current securities

Recent company filings

  1. Regulation FD DisclosureSep 16, 2026
  2. 4 filingSep 8, 2026
  3. 144 filingSep 3, 2026
  4. 144 filingSep 3, 2026
  5. 4 filingAug 20, 2026

Disclosure sections

Items 5.07

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07. Submission of Matters to a Vote of Security Holders. On June 4, 2026, Oscar Health, Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”). As of the close of business on April 10, 2026 (the “Record Date”), there were 265,530,268 shares of Class A common stock outstanding, each share being entitled to one vote, and 35,591,356 shares of Class B common stock outstanding, each share of Class B common stock being entitled to 20 votes. At the Annual Meeting, the holders of 820,307,497 votes of the Common Stock were represented in person or by proxy, constituting a quorum. The stockholders of the Company voted as follows at the Annual Meeting: Proposal 1 – Election of eight director nominees to serve until the 2027 Annual Meeting: Nominee Votes FOR Votes WITHHELD Broker Non-Votes ────────────────────────────────────────────────────────────────────────────────────── Mark T. Bertolini 772,818,926 1,558,102 45,930,469 William J. Gassen III 750,059,354 24,317,674 45,930,469 Joshua Kushner 773,650,856 726,172 45,930,469 Laura Lang 773,617,446 759,582 45,930,469 David Alexander Plouffe 770,608,329 3,768,699 45,930,469 Siddhartha Sankaran 771,818,551 2,558,477 45,930,469 Mario Schlosser 773,697,551 679,477 45,930,469 Vanessa Ames Wittman 772,915,630 1,461,398 45,930,469 Proposal 2 - Advisory vote to approve named executive officer compensation: Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes ───────────────────────────────────────────────────────────────────────────── 765,188,330 8,859,050 329,648 45,930,469 Proposal 3 - Ratification of appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for 2026: Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes ───────────────────────────────────────────────────────────────────────────── 819,470,681 710,425 126,391 – Based on the foregoing votes, the eight director nominees were elected, and Items 2 and 3 were approved.